Acessibilidade / Reportar erro

Pulsatile tinnitus: treatment with clonazepam and propranolol

Abstracts

Pulsatile tinnitus synchronous with heartbeat is rare and normally has vascular origin: arterial (malformation, arterial anatomical variation) or venous (aberrant jugular bulb, glomus tumors, tympanic glomus tumor). Early etiology identification is essential for appropriate treatment to be established. Magnetic angioresonance makes the vascular identification possible and precise. We report a case of arterial anatomical variation in which the treatment was propranolol and clonazepam, showing tinnitus improvement.

pulsatile tinnitus; vascular disease; treatment


O zumbido pulsátil sincrônico com os batimentos cardíacos é pouco freqüente, sendo de etiologia tanto vascular arterial (malformações, fístulas artério-venosas) ou venosa (anormalidades do bulbo jugular, tumor glômico jugular ou timpânico). A identificação precoce da etiologia é essencial para que a terapêutica adequada possa ser instituída. A angioressonância possibilita a identificação de alterações vasculares com maior precisão. Relatamos um caso onde, após o diagnóstico de uma alteração vascular arterial, foi instituído o tratamento com propranolol e clonazepam, com melhora da sintomatologia.

zumbido pulsátil; malformações vasculares; tratamento


CASE REPORT

Pulsatile tinnitus: treatment with clonazepam and propranolol

Sergio AlbertinoI; Aída R. M. de AssunçãoII; Jano A. SouzaIII

IJoint Professor, Universidade Federal Fluminense

IIAssistant Professor, Universidade do Estado do Rio de Janeiro

IIIPh.D. in Neurology, Universidade Federal Fluminense

Correspondence Correspondence to Otorrinos Reunidos Ltda A/C Dr Sérgio Albertino Rua Men de Sá, 186 Icaraí Niterói RJ 24220-261 Tel/fax (55 21) 2710-4278

SUMMARY

Pulsatile tinnitus synchronous with heartbeat is rare and normally has vascular origin: arterial (malformation, arterial anatomical variation) or venous (aberrant jugular bulb, glomus tumors, tympanic glomus tumor). Early etiology identification is essential for appropriate treatment to be established. Magnetic angioresonance makes the vascular identification possible and precise. We report a case of arterial anatomical variation in which the treatment was propranolol and clonazepam, showing tinnitus improvement.

Key words: pulsatile tinnitus, vascular disease, treatment.

INTRODUCTION

Tinnitus is a frequent complaint in the office of otorhinolaryngologists and neurologists, but pulsatile tinnitus synchronous with heartbeat is less frequent and may be caused by different arterial or venous vascular etiologies. Identification of the etiology of this type of tinnitus is essential to define the appropriate therapy and to prevent sequelae that may result from late or incorrect diagnosis. Arterial pulsatile tinnitus may result from malformations of arterial-venous fistulas, atherosclerosis, vascular stenosis, ectopic intratympanic carotid artery, persistence of stapedial artery, stria vascularis aberrant artery, high cardiac output (anemia, thyrotoxicosis). Venous pulsatile tinnitus may be primary (jugular bulb abnormalities, jugular or tympanic glomus tumor) or secondary to intracranial hypertension.

The purpose of the present study was to report a case of tinnitus of arterial vascular etiology that was difficult to solve and the approach followed to reach relief of tinnitus.

CASE REPORT

Male 51-year-old patient without systemic or otological disease, complained of tinnitus of pulsatile nature on the left, synchronous with heartbeat, which had started 9 months before and hindered his professional performance (administrative assistant) and resulted in marked anxiety. The patient had taken antidepressants, anxiolitic and vasoactive drugs prescribed by the neurology, without any response. ENT physical examination presented normal otoscopy and the patient had past history of septoplasty two years before the onset of tinnitus. Neurological examination had no significant findings.

We conducted the following complementary tests:

- Pure tone audiometry - mild decrease in high frequencies (3000Hz 30 dB; 4000Hz 35 dB; 6000Hz 40 dB) bilaterally.

- Brainstem evoked potential did not evidence any abnormalities.

- Nuclear Magnetic Resonance of the head, with gadolinium- isolated focus of reduced signal in T1 and elevated in T2, not impregnated by the contrast medium in the left frontal radial crown, suggestive of cerebral lacuna. Basilar artery was elongated and tortuous, describing anterior-lateral loop on the left under the pons.

- Head angioresonance - brain images in T2 showed hyperintense focus on left radial crown, which may correspond to small area of gliosis or lacuna infarction. Tortuous vertebral-basilar transition towards the pontine-cerebellum angle cistern on the left (Figure 2).



In both neuroimaging studies the other head and vascular structures were normal.

After excluding the hypothesis of surgical treatment, we prescribed clonazepam 2mg/day associated with propranolol 20mg TID, which made tinnitus more tolerable to the patient.

DISCUSSION

Propranolol is an example of a typical beta-blocker. Its main effects are reduction in heart rate and myocardial contractility, reduction of systolic volume, reduction of cardiac output and reduction of arterial blood pressure. Pulsatile tinnitus may be generated by blood flow turbulence caused by vascular malformations that affect vessel lumen, as observed by comparing the normal anatomy of vertebral-basilar system (Figure 1) with the malformation presented by the patient (Figure 2). The use of a beta-blocker aimed at reducing heart rate and arterial flow, maintaining stable blood pressure and reducing perception of tinnitus. The association with clonazepam (long-action benzodiazepine, frequently used to treat tinnitus) was made because of its anxiolitic and myorelaxing effect and it proved to be quite effective with good control of patients' symptomatology.

CLOSING REMARKS

Unilateral pulsatile tinnitus is not normally followed by specific audiometric alterations and should be investigated by neuroimaging exams to be properly diagnosed. In this case there was no indication for surgical intervention and we decided to prescribe benzodiazepine agent associated with beta-blocker to reduce the perception of tinnitus and heart rate allowing the patient to carry on with his daily activities.

REFERENCES

Article submited on July 01, 2003. Article accepted on August 14, 2004.

Discipline of Neurology - Faculdade Fluminense de Medicina - Universidade Federal Fluminense.

Study presented at 36º Congresso Brasileiro de Otorrinolaringologia, Florianópolis SC, 22/11/02.

  • 1
    Albertino S, Moreira Filho PF. Benzodiazepínicos: Atualidades. RBM-ORL 2000; 7(1): 25-7.
  • 2
    Fukuda Y. Zumbido: diagnóstico e tratamento. RBM-ORL 1997; 4(2): 39-43.
  • 3
    Guimarães AC. Farmacologia da angina do peito. In: Silva P. Farmacologia. Rio de Janeiro: Guanabara Koogan; 1980. p. 591-603.
  • 4
    Kauffman EA, Nadaf LC, Souza RT. Diagnóstico diferencial e conduta no zumbido pulsátil. RBORL 2001; 67(2): 253-9.
  • 5
    Moller AR. Tinnitus. In: Jackler RK. & Brackmann DE. Neurotology. St. Louis: Mosby-Year Book Inc.; 1994. p. 153-65.
  • 6
    Sanchez TG, Murao MS, Miranda IRT, Kii MA, Bento RF, Caldas JG et al. Uma nova terapêutica para o tratamento do zumbido pulsátil objetivo de origem venosa. Arquivos da Fundação Otorrinolaringologia 2001; 5(3): 181-6.
  • 7
    Yoo TJ, Shulman A, Brummett RE, Griest SE, Mulkey M, Rubenstein M. Specific Etiologies of Tinnitus. In: Shulman A, Aran JM, Tonndorf J, Feldmann H, Vernon JA. Tinnitus diagnosis/treatment. San Diego: Singular Publishing Group Inc.; 1997. p. 354-65.
  • Correspondence to

    Otorrinos Reunidos Ltda
    A/C Dr Sérgio Albertino
    Rua Men de Sá, 186 Icaraí
    Niterói RJ 24220-261
    Tel/fax (55 21) 2710-4278
  • Publication Dates

    • Publication in this collection
      28 July 2005
    • Date of issue
      Feb 2005

    History

    • Accepted
      14 Aug 2003
    • Received
      01 July 2003
    ABORL-CCF Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial Av. Indianápolis, 740, 04062-001 São Paulo SP - Brazil, Tel./Fax: (55 11) 5052-9515 - São Paulo - SP - Brazil
    E-mail: revista@aborlccf.org.br